"there is an issue that needs to be addressed in terms of the narrative the health trust tried to present and mislead the inquest and cover up what actually happened..
understanding cholesterol effects of adalimumab by new techniques was another goal of gelfand and mehta's study..
the longest one patient waited for treatment following a gp referral in 2017 was 541 days - against a target of 62 days..